Systemic shRNAmousePDX-1 lipoplexes reverse hyperinsulinemia and hypoglycemia and alter glucose tolerance in somatostatin receptor subtypes 1 and 5 (SSTR1/5−/−) knockout mice. This evidence concerns the gene SSTR1 and Hyperinsulinemia.